Cantargia, ABLund, Skane Lan, Sweden
BP21. Myeloid-Stromal IL1RAP as a Therapeutic Vulnerability in Pancreatic Cancer: Rationale for a Neoadjuvant Chemoimmunotherapy Clinical Trial
Friday, March 6, 20261:58 PM - 2:05 PM MST
